Bicara Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Bicara Therapeutics Inc. (BCAX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 435.32 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-11
- Bicara Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 435.32K shares, a 648.66% increase year-over-year.
- Bicara Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 0.00 shares.
- Bicara Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 132.69K shares, a 190.14% increase year-over-year.
- Bicara Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares.
- Bicara Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 190.84K shares, a 16.91% increase from fiscal 2024.
- Bicara Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 163.23K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 435.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 435.32K shares 10-Q · filed 2026-08-11 | 568.02K shares derived: sum of 3 quarters · filed 2026-08-11 | 568.02K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-11 | 132.69K shares derived: sum of 2 quarters · filed 2026-05-11 | 132.69K shares derived: sum of 3 quarters · filed 2026-05-11 | 190.84K shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 132.69K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 132.69K shares derived: sum of 2 quarters · filed 2026-03-30 | 190.84K shares derived: sum of 3 quarters · filed 2026-03-30 | 190.84K shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 58.15K shares derived: sum of 2 quarters · filed 2025-11-10 | 58.15K shares 10-Q · filed 2025-11-10 | 103.88K shares derived: sum of 4 quarters · filed 2025-11-10 |
| 2025-06-30 | 58.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 58.15K shares 10-Q · filed 2025-08-12 | 103.88K shares derived: sum of 3 quarters · filed 2025-08-12 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-13 | 45.73K shares derived: sum of 2 quarters · filed 2025-05-13 | ||
| 2024-12-31 | 45.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 163.23K shares 10-K · filed 2025-03-27 | ||
| 2024-09-30 | 117.49K shares 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |